Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by jojomarchon Dec 17, 2017 9:17am
181 Views
Post# 27173280

RE:RE:Bunge's rationale!

RE:RE:Bunge's rationale!Cuin I really like your post regarding the timelines . I too got fooled based a large part on what we were  told regarding the timelines 3 years ago  . The quality of the doctors was also part of my DD and i'm still satisfied with that . In my case i tend to give a second  chance, a third chance and sometimes even more . I'm like a mother who's son is in custody and still thinks he's a good boy and redeemable . At this point, the compound being safe and tolerable , i think Ph 2 is a sure thing ...timeline ????? I thought they were gonna start to enroll and treat P5-9  30 days after P4 was treated once again i was wrong . They seem to be using this first Ph 1b as a trial and error proccess . The next Ph 1b was to be announced allready so now we wait for early 2018 . As for the financing my guess was a deal ( not a PP ) before the end of october 2017 . On that front i'm not totally frustrated because the more we wait the more data we accumulate and , usually , when your low on cash you tend to be careful with your expenses . Like Toade said the selling pressure should end soon so any positive NR should have a bigger punch bringing the SP up and hopefully keeping it up . I still say the best way to increase the market cap of TLT is to gain recognition and credibility through a partnership with big pharma . A surprise could come along like the " Conditional Nod " mentioned by LaserStock and that would be the ultimate surprise . Anytime the FDA says OK to something SPs go up in multiples . 

HAPPY SUNDAY
Bullboard Posts